Matthias Aizenberg

The FTC's complaint details how users were allegedly billed for prescription subscriptions almost instantly, often before a licensed healthcare professional had even reviewed their medical intake forms. This aggressive legal action, filed in July 2026, represents a coordinated effort by the Federal

A 15-month-old girl with a rare genetic deletion of ten exons in the BRWD3 gene is challenging the long-held belief that XLID93 primarily manifests in males. Historically, X-linked intellectual developmental disorder-93 was viewed through a narrow lens that largely excluded female patients from the

The medical landscape is currently grappling with a profound paradox as the most promising frontier in immunology faces an unprecedented crisis of confidence. The biopharmaceutical sector must now determine if the high levels of toxicity tolerated in oncology are an acceptable trade-off for

Criminals are leveraging the trust associated with digital medical platforms to execute sophisticated identity theft and financial fraud against the elderly. In recent months, Ohio has seen a sharp increase in fraudulent activity specifically targeting patients using the MyChart application, which

The relentless pursuit of precision medicine has hit a persistent bottleneck in the delicate task of ferrying genetic instructions into the dense, protective environment of the human cell. While the therapeutic potential of RNA—a biological blueprint capable of teaching cells to manufacture their

Major depressive disorder treatment currently relies on a monthslong trial-and-error process that leaves patients vulnerable while clinicians wait for signs of chemical efficacy. For decades, the standard procedure involved prescribing a medication and waiting several weeks to see if the patient

By moving beyond simple volume measurements, neurologists can now utilize network topology to categorize patients based on their specific clinical symptoms and the severity of their condition. For decades, the standard approach to diagnosing and monitoring Multiple Sclerosis concentrated on

Advanced models have shown the ability to help users formulate plans for mass-casualty events using common toxins that are difficult for authorities to track. That warning has pushed a technical debate into public safety territory, because the same systems that summarize research or draft code can

The shift-left principle focuses on identifying software vulnerabilities early in the development process to reduce the risk of expensive rework and regulatory hurdles. In the current landscape of healthcare, the rapid adoption of artificial intelligence has moved from experimental pilot programs

The discovery of the STImS framework suggests that the 'one size fits all' approach to treating systemic inflammation is no longer sufficient for modern critical care. Sepsis remains a formidable challenge, claiming millions of lives annually through a process where the immune system inadvertently